Gender matching between donors and recipients important to survival in heart transplantation
Researchers have reported positive results from a safety and efficacy study pertaining to tribendimidine, a broad-based treatment for intestinal worm infections. The group’s results demonstrate the success of the new drug from China versus that of the standard albendazole for the treatment of hookworm, large roundworm, whipworm, and, for the first time, threadworm and
Full Post: Tribendimidine shows promise for intestinal worm infections
Gender matching between donors and recipients is important to short- and long-term survival in heart transplantation, according to a retrospective study presented at the American Heart Association’s Scientific Sessions 2008.
“Heart size would seem to be the most obvious factor; beyond that, no one knows why sex matching is important to transplant survival,” said Eric Weiss, M.D., first author of the study and a post doctoral research fellow in the Division of Cardiac Surgery at The Johns Hopkins University Medical Institutions in Baltimore, Md. “In clinical transplantation, we generally don’t assume that organs from male and female donors have inherent differences affecting long-term outcomes, but our data suggest that there are important differences which must be taken into account.”
Researchers analyzed data from the United Network of Organ Sharing (UNOS), identifying 18,240 patients who received their first orthotopic (replacing a failing organ with a healthy one) heart transplant between 1998 and 2007. In this dataset, patients were followed for 10 years, with the average follow-up time being 3.4 years.
Patients were sorted into four groups: male donor with male recipient, female donor with male recipient, male donor with female recipient, and female donor with female recipient.
Overall, 71 percent were matched by gender to their donor (77 percent of male recipients and 51 percent of female recipients). Twenty-five percent of patients died during the study.
Matching donor and recipient by gender resulted in:
- 13 percent lower risk of graft rejection within the first year;
- 14 percent lower rate of graft rejection over the study period;
- 25 percent drop in 30-day death rate; and
- 20 percent lower one-year death rate.
Statistical modeling revealed that the greatest chance for death during the study occurred when pairing a male donor with a female recipient, which made the risk of death an estimated 20 percent higher compared to a male donor with male recipient. The most successful transplants occurred between male recipients and male donors, when the cumulative chance for survival was 61 percent.
“These results fit with our hypothesis that sex matching in heart transplantation leads to improved survival rates,” said Weiss, the Irene Piccinini Investigator in Cardiac Surgery. “We hypothesized that we would see a big difference in the short-term survival - which we did, most likely because of heart-size issues - but what was interesting was the substantial difference in the long term, as well.”
More than 2,000 transplant surgeries are done each year. Almost 87.5 percent of male recipients and 85.5 percent of female recipients live for more than a year after the transplant, according to American Heart Association statistics.
“We don’t recommend that patients wait longer for a same-sex organ,” Weiss said. “Clearly receiving a heart transplant from a donor of opposite sex is preferable to severe heart failure. If equivalent donors exist for a given patient, our data suggest that picking a sex matched donor may lead to improved short- and long-term survival.”
A Johns Hopkins study finds that HIV-positive kidney transplant recipients could have the same one-year survival rates for themselves and their donor organs as those without HIV, provided certain risk factors for transplant failure are recognized and tightly managed. “Kidney transplantation is a viable and necessary option for HIV-positive patients with chronic kidney disease, especially
Full Post: Kidney transplant survival can be long-term for people with HIV
A new study suggests that patients with hepatitis C (HCV) who need a liver transplant should not receive an organ with high levels of fatty deposits (a.k.a. hepatic steatosis). HCV recurrence was more frequent and earlier among those transplanted with such livers. These findings are in the January issue of Liver Transplantation , a journal
Full Post: Transplanted fatty livers associated with worse prognosis for patients with hepatitis C
While the treatment of heart failure has improved over the past two decades, a new study reported in the European Journal of Heart Failure finds that “the use of evidence-based treatments appears to be imbalanced according to the gender of the patient”. In particular, the study found that female patients were less frequently treated
Full Post: The drug treatment of heart failure is influenced by the gender of the patient and of the physician
A Johns Hopkins transplant surgeon has found strong evidence that women over 45 are significantly less likely to be placed on a kidney transplant list than their equivalent male counterparts, even though women who receive a transplant stand an equal chance of survival. “As woman age, that discrepancy widens to the point where woman over
Full Post: Older women less likely than men to be listed on a kidney transplant list
A unique approach to bone marrow transplantation pioneered in part by a Children’s Hospital of Pittsburgh of UPMC physician has proven to be the only safe and effective cure for sickle cell disease, according to a new study. Lakshmanan Krishnamurti, MD, a pediatric hematologist/oncologist at Children’s Hospital, helped pioneer a form of bone marrow transplantation
Full Post: New approach to bone marrow transplantation found to be a safe and effective cure for sickle cell disease